We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17B
AUM Growth
+$1.79B
Cap. Flow
-$229M
Cap. Flow %
-1.35%
Top 10 Hldgs %
33.75%
Holding
1,490
New
144
Increased
706
Reduced
317
Closed
73

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$448M
2
AMT icon
American Tower
AMT
+$132M
3
HIW icon
Highwoods Properties
HIW
+$92.2M
4
WELL icon
Welltower
WELL
+$79.2M
5
PLD icon
Prologis
PLD
+$71.1M

Top Sells

Rank Stock Value
1
VER
VEREIT, Inc.
VER
+$434M
2
CONE
CyrusOne Inc Common Stock
CONE
+$386M
3
WY icon
Weyerhaeuser
WY
+$118M
4
HR icon
Healthcare Realty
HR
+$68.6M
5
VTR icon
Ventas
VTR
+$64.7M

Sector Composition

Rank Sector Weight
1 Real Estate 60.4%
2 Technology 9.49%
3 Consumer Discretionary 4.17%
4 Communication Services 4.01%
5 Financials 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YMAB
1276
DELISTED
Y-mAbs Therapeutics
YMAB
$2K ﹤0.01%
149
– –
LENZ
1277
LENZ Therapeutics
LENZ
$184M
$2K ﹤0.01%
+24
New +$1.99K
TVRD
1278
Tvardi Therapeutics
TVRD
$22.9M
$2K ﹤0.01%
5
– –
CMRX
1279
DELISTED
Chimerix, Inc.
CMRX
$2K ﹤0.01%
+253
New +$1.52K
OMGA
1280
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$2K ﹤0.01%
+139
New +$2.64K
PETQ
1281
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
– –
ME
1282
DELISTED
23andMe Holding Co
ME
$2K ﹤0.01%
+18
New +$3.32K
EGRX
1283
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2K ﹤0.01%
30
– –
OMIC
1284
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$2K ﹤0.01%
+7
New +$2.71K
DCPH
1285
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2K ﹤0.01%
199
– –
KNTE
1286
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$2K ﹤0.01%
+127
New +$2.68K
AMTI
1287
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$2K ﹤0.01%
132
– –
KDNY
1288
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2K ﹤0.01%
153
– –
BLU
1289
DELISTED
BELLUS Health Inc.
BLU
$2K ﹤0.01%
+229
New +$1.52K
IMGO
1290
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$2K ﹤0.01%
+98
New +$2.27K
FMTX
1291
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2K ﹤0.01%
162
– –
ACET icon
1292
Adicet Bio
ACET
$76.7M
$1K ﹤0.01%
4
– –
ACIU icon
1293
AC Immune
ACIU
$236M
$1K ﹤0.01%
158
– –
AKBA icon
1294
Akebia Therapeutics
AKBA
$341M
$1K ﹤0.01%
316
– –
ALGS icon
1295
Aligos Therapeutics
ALGS
$26.3M
$1K ﹤0.01%
+5
New +$1.82K
ALT icon
1296
Altimmune
ALT
$581M
$1K ﹤0.01%
136
– –
LONA
1297
LeonaBio Inc
LONA
$65.5M
$1K ﹤0.01%
+11
New +$1.39K
AVDL
1298
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
120
– –
BDTX icon
1299
Black Diamond Therapeutics
BDTX
$101M
$1K ﹤0.01%
106
+38
+56% +$265
CGEN icon
1300
Compugen
CGEN
$214M
$1K ﹤0.01%
156
– –
50 51
52
53 54

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2021 Portfolio in Review

As of Q4 2021, Daiwa Securities Group held 1,490 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q4 2021 filing shows 144 new, 706 increased, 317 reduced and 73 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M. The largest sale was VEREIT, Inc., an estimated $434M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2021 buy was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M.
  • Daiwa Securities Group added most to Realty Income in Q4 2021, an estimated $448M increase.
  • Daiwa Securities Group's biggest Q4 2021 reduction was CyrusOne Inc Common Stock, cutting an estimated $386M.
  • Daiwa Securities Group fully exited VEREIT, Inc. in Q4 2021, selling an estimated $434M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $17B portfolio in Q4 2021.
  • Daiwa Securities Group opened 144 new positions and closed 73 in Q4 2021.
  • Daiwa Securities Group's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.